210 related articles for article (PubMed ID: 31871221)
1. Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium.
Rendle KA; Burnett-Hartman AN; Neslund-Dudas C; Greenlee RT; Honda S; Elston Lafata J; Marcus PM; Cooley ME; Vachani A; Meza R; Oshiro C; Simoff MJ; Schnall MD; Beaber EF; Doria-Rose VP; Doubeni CA; Ritzwoller DP
Cancer Prev Res (Phila); 2020 Feb; 13(2):129-136. PubMed ID: 31871221
[TBL] [Abstract][Full Text] [Related]
2. Accelerating integration of tobacco use treatment in the context of lung cancer screening: Relevance and application of implementation science to achieving policy and practice.
Shelley D; Wang VH; Taylor K; Williams R; Toll B; Rojewski A; Foley KL; Rigotti N; Ostroff JS
Transl Behav Med; 2022 Nov; 12(11):1076-1083. PubMed ID: 36227937
[TBL] [Abstract][Full Text] [Related]
3. Evaluating efficacy of current lung cancer screening guidelines.
Nemesure B; Plank A; Reagan L; Albano D; Reiter M; Bilfinger TV
J Med Screen; 2017 Dec; 24(4):208-213. PubMed ID: 28201949
[TBL] [Abstract][Full Text] [Related]
4. Uptake of Lung Cancer Screening CT After a Provider Order for Screening in the PROSPR-Lung Consortium.
Neslund-Dudas C; Tang A; Alleman E; Zarins KR; Li P; Simoff MJ; Lafata JE; Rendle KA; Hartman ANB; Honda SA; Oshiro C; Olaiya O; Greenlee RT; Vachani A; Ritzwoller DP
J Gen Intern Med; 2024 Feb; 39(2):186-194. PubMed ID: 37783984
[TBL] [Abstract][Full Text] [Related]
5. Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement.
Rivera MP; Katki HA; Tanner NT; Triplette M; Sakoda LC; Wiener RS; Cardarelli R; Carter-Harris L; Crothers K; Fathi JT; Ford ME; Smith R; Winn RA; Wisnivesky JP; Henderson LM; Aldrich MC
Am J Respir Crit Care Med; 2020 Oct; 202(7):e95-e112. PubMed ID: 33000953
[No Abstract] [Full Text] [Related]
6. Screening for lung cancer: 2023 guideline update from the American Cancer Society.
Wolf AMD; Oeffinger KC; Shih TY; Walter LC; Church TR; Fontham ETH; Elkin EB; Etzioni RD; Guerra CE; Perkins RB; Kondo KK; Kratzer TB; Manassaram-Baptiste D; Dahut WL; Smith RA
CA Cancer J Clin; 2024; 74(1):50-81. PubMed ID: 37909877
[TBL] [Abstract][Full Text] [Related]
7. Development of an Electronic Health Record-Based Algorithm for Predicting Lung Cancer Screening Eligibility in the Population-Based Research to Optimize the Screening Process Lung Research Consortium.
Burnett-Hartman AN; Powers JD; Hixon BP; Carroll NM; Frankland TB; Honda SA; Saia C; Rendle KA; Greenlee RT; Neslund-Dudas C; Zheng Y; Vachani A; Ritzwoller DP
JCO Clin Cancer Inform; 2023 Sep; 7():e2300063. PubMed ID: 37910824
[TBL] [Abstract][Full Text] [Related]
8. The 10 Pillars of Lung Cancer Screening: Rationale and Logistics of a Lung Cancer Screening Program.
Fintelmann FJ; Bernheim A; Digumarthy SR; Lennes IT; Kalra MK; Gilman MD; Sharma A; Flores EJ; Muse VV; Shepard JA
Radiographics; 2015; 35(7):1893-908. PubMed ID: 26495797
[TBL] [Abstract][Full Text] [Related]
9. Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda.
Beaber EF; Kamineni A; Burnett-Hartman AN; Hixon B; Kobrin SC; Li CI; Oliver M; Rendle KA; Skinner CS; Todd K; Zheng Y; Ziebell RA; Breslau ES; Chubak J; Corley DA; Greenlee RT; Haas JS; Halm EA; Honda S; Neslund-Dudas C; Ritzwoller DP; Schottinger JE; Tiro JA; Vachani A; Doria-Rose VP
Cancer Epidemiol Biomarkers Prev; 2022 Aug; 31(8):1521-1531. PubMed ID: 35916603
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data.
Williams RM; Li T; Luta G; Wang MQ; Adams-Campbell L; Meza R; Tammemägi MC; Taylor KL
Cancer; 2022 May; 128(9):1812-1819. PubMed ID: 35201610
[TBL] [Abstract][Full Text] [Related]
11. An integrated digital/clinical approach to smoking cessation in lung cancer screening: study protocol for a randomized controlled trial.
Graham AL; Burke MV; Jacobs MA; Cha S; Croghan IT; Schroeder DR; Moriarty JP; Borah BJ; Rasmussen DF; Brookover MJ; Suesse DB; Midthun DE; Hays JT
Trials; 2017 Nov; 18(1):568. PubMed ID: 29179734
[TBL] [Abstract][Full Text] [Related]
12. A protocol for a cluster randomized trial of care delivery models to improve the quality of smoking cessation and shared decision making for lung cancer screening.
Lowenstein LM; Shih YT; Minnix J; Lopez-Olivo MA; Maki KG; Kypriotakis G; Leal VB; Shete SS; Fox J; Nishi SP; Cinciripini PM; Volk RJ
Contemp Clin Trials; 2023 May; 128():107141. PubMed ID: 36878389
[TBL] [Abstract][Full Text] [Related]
13. Utilization of Lung Cancer Screening in the Medicare Fee-for-Service Population.
Tailor TD; Tong BC; Gao J; Henderson LM; Choudhury KR; Rubin GD
Chest; 2020 Nov; 158(5):2200-2210. PubMed ID: 32562612
[TBL] [Abstract][Full Text] [Related]
14. Improving Utilization of Lung Cancer Screening Through Incorporating a Video-Based Educational Tool Into Smoking Cessation Counseling.
Raz DJ; Ismail MH; Haupt EC; Sun V; Park S; Alem AC; Gould MK
Clin Lung Cancer; 2021 Mar; 22(2):83-91. PubMed ID: 33436279
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Uptake Appropriateness of Computed Tomography for Lung Cancer Screening According to Patients Meeting Eligibility Criteria of the US Preventive Services Task Force.
Liu Y; Pan IE; Tak HJ; Vlahos I; Volk R; Shih YT
JAMA Netw Open; 2022 Nov; 5(11):e2243163. PubMed ID: 36409492
[TBL] [Abstract][Full Text] [Related]
16. Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs.
Armstrong K; Kim JJ; Halm EA; Ballard RM; Schnall MD
Cancer; 2016 May; 122(9):1338-42. PubMed ID: 26929386
[TBL] [Abstract][Full Text] [Related]
17. The OaSiS trial: A hybrid type II, national cluster randomized trial to implement smoking cessation during CT screening for lung cancer.
Foley KL; Miller DP; Weaver K; Sutfin EL; Petty WJ; Bellinger C; Spangler J; Stone RJ; Lawler D; Davis W; Dressler E; Lesser G; Chiles C
Contemp Clin Trials; 2020 Apr; 91():105963. PubMed ID: 32087340
[TBL] [Abstract][Full Text] [Related]
18. Racial Disparities in Lung Cancer Screening: An Exploratory Investigation.
Japuntich SJ; Krieger NH; Salvas AL; Carey MP
J Natl Med Assoc; 2018 Oct; 110(5):424-427. PubMed ID: 30129479
[TBL] [Abstract][Full Text] [Related]
19. State-Level Variations in the Utilization of Lung Cancer Screening Among Medicare Fee-for-Service Beneficiaries: An Analysis of the 2015 to 2017 Physician and Other Supplier Data.
Liu B; Dharmarajan K; Henschke CI; Taioli E
Chest; 2020 Apr; 157(4):1012-1020. PubMed ID: 31759960
[TBL] [Abstract][Full Text] [Related]
20. Translating New Lung Cancer Screening Guidelines into Practice: The Experience of One Community Hospital.
Ledford CJ; Gawrys BL; Wall JL; Saas PD; Seehusen DA
J Am Board Fam Med; 2016; 29(1):152-5. PubMed ID: 26769888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
